137719 <common-name>VEGFR2-169</common-name> <description>VEGFR2-169 belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 1,073 g/mol, VEGFR2-169 is a heavy molecule. The chemical formula for this compound is C47H76N16O13.</description> <cas>673478-49-4</cas> <pubchem-id>25210976</pubchem-id> <chemical-formula>C47H76N16O13</chemical-formula> <weight nil="true"/> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-14T20:38:00Z</created-at> <updated-at type="dateTime">2026-05-14T19:56:07Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id>DB16152</drugbank-id> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C(O)=O</moldb-smiles> <moldb-formula>C47H76N16O13</moldb-formula> <moldb-inchi>InChI=1S/C47H76N16O13/c1-5-25(4)37(45(75)76)62-40(70)28(15-10-18-55-47(52)53)58-41(71)30(21-33(49)64)57-34(65)23-56-39(69)31(22-35(66)67)60-43(73)32-16-11-19-63(32)44(74)36(24(2)3)61-42(72)29(20-26-12-7-6-8-13-26)59-38(68)27(48)14-9-17-54-46(50)51/h6-8,12-13,24-25,27-32,36-37H,5,9-11,14-23,48H2,1-4H3,(H2,49,64)(H,56,69)(H,57,65)(H,58,71)(H,59,68)(H,60,73)(H,61,72)(H,62,70)(H,66,67)(H,75,76)(H4,50,51,54)(H4,52,53,55)/t25-,27-,28-,29-,30-,31-,32-,36-,37-/m0/s1</moldb-inchi> <moldb-inchikey>ZAJHBCDPAUKEPU-GIKXZWSFSA-N</moldb-inchikey> <moldb-average-mass type="decimal">1073.224</moldb-average-mass> <moldb-mono-mass type="decimal">1072.577776571</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>-8.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM133612</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(2S,3S)-2-[(2S)-2-[(2S)-2-{2-[(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]acetamido}-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer">54</paper-count> <sync-id>CED0022952</sync-id> <structure-inchikey>ZAJHBCDPAUKEPU-GIKXZWSFSA-N</structure-inchikey> <structure-fingerprint>40000000004000000081800000080400000900000004000044000000000020000000001002000000000000002000008004000008000000020000000000800010000010000000000400000000000180000020001000004000080000009000000000002000010000000400404000100022000000020100004000000100000000300800000040200000800082020000040080001000000100000000000000000000012000000004400100000000080040000000000080100000008000000000002200800000010000000000a00000000000000000000000110000400220000400400000000100000840000048000020010400000000000000000000020088000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAABMAAAATQAAAIABBgBgAAAAAQMGAGAAAAAC AgYgNAAAAAIBBAYAYAAAAAEDBiA0AAAAAgEEBwBoAAAAAwIBBgAoAAAAAwQI ACgAAAADAgYgNAAAAAIBBAYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgcAaAAA AAMCAQYAKAAAAAMEBwBoAAAAAwECBwBoAAAAAwIBBwBoAAAAAwIBBgAoAAAA AwQIACgAAAADAgYgNAAAAAIBBAYAYAAAAAICBgAoAAAAAwQHAGgAAAADAQII ACgAAAADAgcAaAAAAAMCAQYAKAAAAAMECAAoAAAAAwIGAGAAAAACAgcAaAAA AAMCAQYAKAAAAAMECAAoAAAAAwIGIDQAAAACAQQGAGAAAAACAgYAKAAAAAME CABoAAAAAwEBCAAoAAAAAwIHAGgAAAADAgEGACgAAAADBAgAKAAAAAMCBiA0 AAAAAgEEBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBwAoAAAAAwMGACgAAAAD BAgAKAAAAAMCBiA0AAAAAQEEBwBoAAAAAwIBBgAoAAAAAwQIACgAAAADAgYg NAAAAAIBBAYAYAAAAAICBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgA AAADAwEGQGgAAAADAwEGQGgAAAADAwEHAGgAAAADAgEGACgAAAADBAgAKAAA AAMCBiA0AAAAAQEEBwBgAAAAAQIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIH AGgAAAADAgEGACgAAAADBAcAaAAAAAMBAgcAaAAAAAMCAQYAYAAAAAMBBgBg AAAAAQMGAGAAAAABAwYAKAAAAAMECABoAAAAAwEBCAAoAAAAAwILAAEAAQIA AgMAAgQABAUABQYgBgcoAgYIAAgJAAkKAAoLAAsMAAwNIA0OIA0PKAIIEAAQ ESAREigCERMAExQAFBUAFRYgFRcoAhMYABgZIBkaKAIZGwAbHAAcHSAdHigC HR8AHyAAICEAISIgISMoAh8kACQlICUmKAIlJwAnKAAoKQApKgAqKwArLCAs LSgCLC4ALi8ALzAgMDEoAjAyADIzADM0ADQ1aAw1NmgMNjdoDDc4aAw4OWgM MjoAOjsgOzwoAjs9AD0+AD0/AD9AAEBBAEFCAEJDIENEIENFKAIuRgBGRwBG SAAESQBJSiBJSygCKycAOTRoDEICAAAABScoKSorBjU2Nzg5NBcEAAAAAAAA ABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:50:33Z</structure-indexed-at> </compound>